In cancerous cells, the ubiquitination of specific RPs can promote tumour invasion, tumour metastasis, and resistance to chemotherapy treatment, thereby contributing to tumour progression (see sections on RPL5, RPL11, RPS3, and RPL23a). Here, RPL5 is linked to neoplasm.